Pathfinder Cell Therapy (PFND) Return on Assets ROA from the third quarter of 2015 to third quarter of 2014 and for the year 2015, Average High and Low, Fundamental Ratios from Sep 30 2015 to Sep 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pathfinder Cell Therapy, Inc.  (PFND)


Pathfinder Cell Therapy's ROA from the third quarter of 2015 to the third quarter of 2014 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Pathfinder Cell Therapy's ROA in the third quarter of 2015?
Due to the lack of assets, it was not possible to calculate Pathfinder Cell Therapy, Inc.'s return on assets (ROA) in its third quarter of 2015

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Total Assets Change -44.29 % -32.88 % -39.44 % -31.61 % -66.35 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -1 -1 -1 -1 -1
Return On Assets (TTM) -1542.86 % -1382.64 % -1414.93 % -1426.09 % -1351.82 %
PFND's Total Ranking # 5589 # 5672 # 5714 # 5874 # 5483
Total Assets (TTM) in million 0 0 0 0 0
Seq. Total Assets Change -20.41 % -43.02 % -18.87 % 51.43 % -4.11 %
Seq. Net Income Change - - - - -

PFND's 5 Years Annual ROA >> Back to PFND Management Effectiveness >> Compare PFND ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 173
Sector # 663
Overall # 4478

Return On Assets Statistics
High Average Low
-432.27 %
-1006.18 %
-1542.86 %
(Sep 30 2012)   (Sep 30 2015)





Financial Statements
Pathfinder Cell Therapy's Assets $ 0 million PFND's Balance sheet
Pathfinder Cell Therapy's Income $ 0 million Quarterly PFND's Income Statement
PFND's Income by Division See PFND's Income by Division



Annual Return On Assets (Dec 31 2014)
FY 2014		 (Dec 31 2013)
FY 2013		 (Dec 31 2012)
FY 2012		 (Dec 31 2010)
FY 2011
FY
Y / Y Total Assets Change -31.61 % -56.46 % 85.42 % - -
Total Assets in million 0 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -1 -2 -2 -1 0
Annual Return On Assets -1315.09 % -1100 % -605.62 % -673.96 % -

PFND's 5 Years Annual ROA >> Back to PFND Management Effectiveness >> Compare PFND ROA to its Competitors



More Return On Assets Ratios
PFND's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PFND's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PFND's Competitors
Subscribers only: Roa for Pathfinder Cell Therapy's Suppliers
Subscribers only: Return On Assets for PFND's Customers

You may also want to know
PFND's Roi PFND's Inventory Turnover Ratio PFND's Growth Rates PFND's Dividend Comparisons
PFND's Profitability Ratios PFND's Asset Turnover Ratio PFND's Dividend Growth
PFND's Roe PFND's Valuation Ratios PFND's Financial Strength Ratios PFND's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2015, within Healthcare Sector ROA

Date modified: 2026-09-08T15:08:00+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.